{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T09:35:49Z","timestamp":1767951349371,"version":"3.49.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100009336","name":"Bengt Ihres Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001725","name":"Royal Swedish Academy of Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007687","name":"Svenska L\u00e4kares\u00e4llskapet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007687","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.ejso.2025.111159","type":"journal-article","created":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T07:48:05Z","timestamp":1761810485000},"page":"111159","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Assessing surgical resection in recurrent biliary tract cancer: International two-centre experience"],"prefix":"10.1016","volume":"52","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7137-7305","authenticated-orcid":false,"given":"Yoshiyuki","family":"Shibata","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1833-854X","authenticated-orcid":false,"given":"Hannes","family":"Jansson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5144-351X","authenticated-orcid":false,"given":"Kosuke","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-4244-5016","authenticated-orcid":false,"given":"William","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Oba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2102-7168","authenticated-orcid":false,"given":"Poya","family":"Ghorbani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiro","family":"Ono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melroy A.","family":"D'Souza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3451-2840","authenticated-orcid":false,"given":"Christian","family":"Sturesson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiromichi","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0259-8328","authenticated-orcid":false,"given":"Ernesto","family":"Sparrelid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5812-6608","authenticated-orcid":false,"given":"Yosuke","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Gilg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejso.2025.111159_bib1","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1097\/00000658-200110000-00010","article-title":"Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma","volume":"234","author":"Jarnagin","year":"2001","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejso.2025.111159_bib2","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/01.sla.0000150166.94732.88","article-title":"Actual long-term outcome of extrahepatic bile duct cancer after surgical resection","volume":"241","author":"Jang","year":"2005","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejso.2025.111159_bib3","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1097\/SLA.0b013e318176c4d3","article-title":"Intrahepatic cholangiocarcinoma: rising frequency, improved survival, and determinants of outcome after resection","volume":"248","author":"Endo","year":"2008","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejso.2025.111159_bib4","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1002\/cncr.11699","article-title":"Patterns of initial disease recurrence after resection of gallbladder carcinoma and hilar cholangiocarcinoma: implications for adjuvant therapeutic strategies","volume":"98","author":"Jarnagin","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.ejso.2025.111159_bib5","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1002\/bjs.6788","article-title":"Disease recurrence patterns after R0 resection of hilar cholangiocarcinoma","volume":"97","author":"Kobayashi","year":"2010","journal-title":"Br J Surg"},{"key":"10.1016\/j.ejso.2025.111159_bib6","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1002\/bjs.10452","article-title":"Recurrence after resection with curative intent for distal cholangiocarcinoma","volume":"104","author":"Komaya","year":"2017","journal-title":"Br J Surg"},{"key":"10.1016\/j.ejso.2025.111159_bib7","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1093\/annonc\/mdz402","article-title":"Combination gemcitabine plus S-1 versus gemcitabine plus cisplatin for advanced\/recurrent biliary tract cancer: the FUGA-BT (JCOG1113) randomized phase III clinical trial","volume":"30","author":"Morizane","year":"2019","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejso.2025.111159_bib8","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1002\/jhbp.1219","article-title":"Randomized phase III study of gemcitabine, cisplatin plus S-1 versus gemcitabine, cisplatin for advanced biliary tract cancer (KHBO1401- MITSUBA)","volume":"30","author":"Ioka","year":"2023","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"10.1016\/j.ejso.2025.111159_bib9","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDoa2200015","article-title":"Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer","volume":"1","author":"Oh","year":"2022","journal-title":"NEJM Evid"},{"key":"10.1016\/j.ejso.2025.111159_bib10","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.amjsurg.2008.12.035","article-title":"Intrahepatic cholangiocarcinoma: analysis of 44 consecutive resected cases including 5 cases with repeat resections","volume":"201","author":"Saiura","year":"2011","journal-title":"Am J Surg"},{"key":"10.1016\/j.ejso.2025.111159_bib11","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1097\/SLA.0000000000000827","article-title":"Surgery for recurrent biliary tract cancer: a single-center experience with 74 consecutive resections","volume":"262","author":"Takahashi","year":"2015","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejso.2025.111159_bib12","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/ags3.12036","article-title":"Clinical implication of surgical resection for recurrent biliary tract cancer: does it work or not?","volume":"1","author":"Miyazaki","year":"2017","journal-title":"Ann Gastroenterol Surg"},{"key":"10.1016\/j.ejso.2025.111159_bib13","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s12957-015-0507-8","article-title":"Surgery for recurrent biliary carcinoma: results for 27 recurrent cases","volume":"13","author":"Noji","year":"2015","journal-title":"World J Surg Oncol"},{"key":"10.1016\/j.ejso.2025.111159_bib14","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1007\/s00268-017-4107-3","article-title":"Survival benefits of surgical resection in patients with recurrent biliary tract carcinoma","volume":"41","author":"Motoyama","year":"2017","journal-title":"World J Surg"},{"key":"10.1016\/j.ejso.2025.111159_bib15","doi-asserted-by":"crossref","first-page":"4171","DOI":"10.1245\/s10434-020-08534-2","article-title":"Time to recurrence after surgical resection and survival after recurrence among patients with perihilar and distal cholangiocarcinomas","volume":"27","author":"Nakanishi","year":"2020","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2025.111159_bib16","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1245\/s10434-019-07353-4","article-title":"Recurrence patterns and timing courses following curative-intent resection for intrahepatic cholangiocarcinoma","volume":"26","author":"Hu","year":"2019","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2025.111159_bib17","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1007\/s00268-017-4387-7","article-title":"Long-term survival of recurrent intrahepatic cholangiocarcinoma: the impact and selection of repeat surgery","volume":"42","author":"Yoh","year":"2018","journal-title":"World J Surg"},{"key":"10.1016\/j.ejso.2025.111159_bib18","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1245\/s10434-015-4642-9","article-title":"Management and outcomes of patients with recurrent intrahepatic cholangiocarcinoma following previous curative-intent surgical resection","volume":"23","author":"Spolverato","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2025.111159_bib19","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1002\/bjs5.50217","article-title":"Outcome after liver resection for primary and recurrent intrahepatic cholangiocarcinoma","volume":"3","author":"Nickkholgh","year":"2019","journal-title":"BJS Open"},{"key":"10.1016\/j.ejso.2025.111159_bib20","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1093\/bjs\/znac075","article-title":"Repeat liver resection for recurrent intrahepatic cholangiocarcinoma: meta-analysis","volume":"109","author":"Ramouz","year":"2022","journal-title":"Br J Surg"},{"key":"10.1016\/j.ejso.2025.111159_bib21","doi-asserted-by":"crossref","first-page":"3348","DOI":"10.1245\/s10434-023-13190-3","article-title":"Role of intraoperative assessment of proximal bile duct margin status and additional resection of perihilar cholangiocarcinoma: can local clearance trump tumor biology? A retrospective cohort study","volume":"30","author":"Kawano","year":"2023","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2025.111159_bib22","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0140-6736(22)02038-4","article-title":"Adjuvant S-1 compared with observation in resected biliary tract cancer (JCOG1202, ASCOT): a multicentre, open-label, randomised, controlled, phase 3 trial","volume":"401","author":"Nakachi","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.ejso.2025.111159_bib23","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S1470-2045(18)30915-X","article-title":"Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study","volume":"20","author":"Primrose","year":"2019","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejso.2025.111159_bib24","series-title":"TNM classification of malignant tumors eighth edition","author":"Brierley","year":"2017"},{"key":"10.1016\/j.ejso.2025.111159_bib25","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1093\/aje\/kwi307","article-title":"Survival bias associated with time-to-treatment initiation in drug effectiveness evaluation: a comparison of methods","volume":"162","author":"Zhou","year":"2005","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.ejso.2025.111159_bib26","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.amjsurg.2019.02.015","article-title":"Effectiveness of surgery for recurrent cholangiocarcinoma: a single center experience and brief literature review","volume":"219","author":"Kitano","year":"2020","journal-title":"Am J Surg"},{"key":"10.1016\/j.ejso.2025.111159_bib27","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/j.hpb.2021.01.007","article-title":"Oncological outcomes of surgery for recurrent biliary tract cancer: who are the best candidates?","volume":"23","author":"Sakata","year":"2021","journal-title":"HPB (Oxford)"},{"key":"10.1016\/j.ejso.2025.111159_bib28","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1200\/JCO.1995.13.1.8","article-title":"Oligometastases","volume":"13","author":"Hellman","year":"1995","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejso.2025.111159_bib29","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2019-033452","article-title":"Simultaneous resection of the primary tumour and liver metastases after conversion chemotherapy versus standard therapy in pancreatic cancer with liver oligometastasis: protocol of a multicentre, prospective, randomised phase III control trial (CSPAC-1)","volume":"9","author":"Wei","year":"2019","journal-title":"BMJ Open"},{"key":"10.1016\/j.ejso.2025.111159_bib30","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1016\/S0140-6736(23)00727-4","article-title":"Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"401","author":"Kelley","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.ejso.2025.111159_bib31","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S1470-2045(20)30109-1","article-title":"Pemigatinib for previously treated, locally advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 study","volume":"21","author":"Abou-Alfa","year":"2020","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejso.2025.111159_bib32","doi-asserted-by":"crossref","DOI":"10.1093\/oncolo\/oyae256","article-title":"Efficacy of cisplatin-gemcitabine-durvalumab in patients with advanced biliary tract cancer experiencing early vs late disease relapse after surgery: a large real-life worldwide population","volume":"30","author":"Lo Prinzi","year":"2025","journal-title":"Oncologist"},{"key":"10.1016\/j.ejso.2025.111159_bib33","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrgastro.2016.51","article-title":"Expert consensus document: cholangiocarcinoma: current knowledge and future perspectives consensus statement from the european network for the study of cholangiocarcinoma (ENS-CCA)","volume":"13","author":"Banales","year":"2016","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"Suppl 1","key":"10.1016\/j.ejso.2025.111159_bib34","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/liv.14095","article-title":"Cholangiocarcinoma: epidemiology and risk factors","volume":"39","author":"Khan","year":"2019","journal-title":"Liver Int"},{"key":"10.1016\/j.ejso.2025.111159_bib35","doi-asserted-by":"crossref","DOI":"10.1093\/bjsopen\/zraf019","article-title":"Western and eastern experience in treating perihilar cholangiocarcinoma: retrospective bi-centre study","volume":"9","author":"Jansson","year":"2025","journal-title":"BJS Open"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798325015872?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798325015872?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T07:56:55Z","timestamp":1767945415000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798325015872"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S0748798325015872"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2025.111159","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessing surgical resection in recurrent biliary tract cancer: International two-centre experience","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2025.111159","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111159"}}